₹320.75
-1.44% today
· 30d -2.21%
as of 2026-09-04
Price · Daily Candles
“Bajaj Healthcare's Profit Plunge: Q4 Net Profit Sinks 304% YoY as FIIs Step Up Stake.”
Bajaj Healthcare faces significant profitability challenges, reporting a Q4 FY26 net loss of ₹23 crore and a staggering -304.43% YoY net profit decline. Despite this, the company's annual revenue rose 12.61% for FY26 to ₹611 crore. FIIs increased their stake by 0.45% QoQ to 1.98% by March 2026, even as the stock price declined -46.38% over the last year.
BULL CASE
+Annual revenue witnessed a 12.61% increase in FY26, reaching ₹611 crore.
+Operating profit in Q4 FY26 saw a marginal 1.2% YoY increase to ₹26 crore despite net profit decline.
+FIIs increased their shareholding by 0.45% QoQ, holding 1.98% as of March 2026.
+The company's OPM in Q4 FY26 improved slightly by 1.36% YoY to 16.43%.
BEAR CASE
−Net profit in Q4 FY26 plummeted by -304.43% YoY to a loss of ₹23 crore, with annual net profit down -60.08% to ₹16 crore.
−The stock price has seen a significant decline of -46.38% over the last year and is 49.66% off its 52-week high of ₹608.9.
−EPS for Q4 FY26 turned negative to -₹6.08.
−The stock trades at a TTM PE of 45.42 and is flagged as 'overvalued' with an intrinsic value of ₹24.07, indicating a -92.1% margin of safety.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹166 Cr
+11.28% YoY
NET PROFIT
₹14 Cr
+15.75% YoY
OPM
17.76%
+0.8pp YoY
EPS
₹4.13
PE 45.42
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-50.0%, h2=-50.0%, h3=-50.0% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
Bajaj Healthcare's PE of 45.42 places it above peers like Dr. Reddy's (PE 19.55) and Zydus Life Sciences (PE 21.54), contrasting with industry leaders such as Cipla (ROCE 25.09%) and Sun Pharma (PE 40.41).
PEERPEROCE %
BAJAJHCARE45.42—
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
48
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
UNDERPERFORMER
20
Valuation
FAIR
40
Growth
MUTED
43
Profitability
HIGH
75
Technicals
NEUTRAL
62
Risk
MODERATE
50
Key Stats
TTM PE
45.42
P/B
1.83
52W HIGH
₹515.9
OFF HIGH
-37.83%
DIV YIELD
0.33%
MKT CAP
₹1075 Cr
◉ Active Signals
MACDNeutral0.3401
RSI(14)Neutral45.48
⧉ Strategy Fit 🔒